Loading content…
Affiliate-supportedIndependent editorialWe never sell medicationSee how
West · Nevada
Local context for Wegovy, Ozempic, Mounjaro, and Zepbound in Las Vegas (660,000 residents, 2,330,000 metro). Nevada Medicaid covers T2D GLP-1s with prior auth; UMC is the only public hospital in Clark County.
Availability and prices vary by pharmacy and date. We do not maintain real-time per-pharmacy stock data. Confirm with pharmacies directly.
Wegovy
semaglutide · Novo Nordisk
Once-weekly semaglutide injection FDA-approved for chronic weight management in adults and adolescents.
Wegovy in Las Vegas →
Ozempic
semaglutide · Novo Nordisk
Once-weekly semaglutide injection FDA-approved for adults with type 2 diabetes.
Ozempic in Las Vegas →
Mounjaro
tirzepatide · Eli Lilly
Once-weekly tirzepatide injection FDA-approved for adults with type 2 diabetes.
Mounjaro in Las Vegas →
Zepbound
tirzepatide · Eli Lilly
Once-weekly tirzepatide injection FDA-approved for chronic weight management and obstructive sleep apnea.
Zepbound in Las Vegas →
Las Vegas is a west-region city with a population of 660,000 (2,330,000 in the broader metropolitan area). Nevada expanded Medicaid under the Affordable Care Act, which means low-income adults can typically qualify for GLP-1 coverage for type 2 diabetes if the state Medicaid program lists the drug.
Statewide, notable health systems include University Medical Center of Southern Nevada, Renown Health.
Nevada's Medicaid program is Nevada Medicaid. Coverage rules for GLP-1 medications vary by drug and indication; see our pricing by state map and payer-coverage guides for details.
Cities of similar size with comparable healthcare markets.